Follow The Filings

SOPH Sophia Genetics SA

Information Technology, filed as SOPHIA GENETICS SA (ORDINARY SHARES), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.4%
  • $21M

Who owns this now

Largest portfolio weights among holders, up to 0.4% (Chuck Akre, Akre Capital Management). Not free-float ownership.

  1. Chuck Akre 0.42%

Who owns SOPH

Sorted by value, long equity only, as of 2026 Q2.

History
Chuck Akre, Akre Capital Management 0.42% Hold 3,719,140 $21M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by SOPH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SOPH insider trades
  • $99K bought by 1 insider
  • None no sales outside a trading plan
  • $3.2M sold by 7 insiders under 10b5-1 plans
  1. Philippe Menu Chief Medical Officer
    Planned sale
    $36K 5,000 shares at $7.26 2.5% of stake
    Traded Oct 12 Filed Oct 14
    ↗
  2. Zhenyu Xu Chief Scientific Officer
    Planned sale
    $29K 4,000 shares at $7.18 0.7% of stake
    Traded Oct 13 Filed Oct 14
    ↗
  3. Jurgi Camblong Chair
    Planned sale
    $62K 8,500 shares at $7.26 0.3% of stake
    Traded Oct 12 Filed Oct 14
    ↗
  4. Philippe Menu Chief Medical Officer
    Planned sale
    $39K 5,000 shares at $7.88 2.3% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  5. Zhenyu Xu Chief Scientific Officer
    Planned sale
    $32K 4,000 shares at $7.88 0.7% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  6. Daan Van Well Chief Legal Officer
    Planned sale
    $47K 6,168 shares at $7.63 1.8% of stake
    Traded Sep 11 Filed Sep 14
    ↗
  7. Jurgi Camblong Chair
    Planned sale
    $65K 8,500 shares at $7.66 0.2% of stake
    Traded Sep 10 Filed Sep 14
    ↗
  8. Kathy L Hibbs Director
    Planned sale
    $51K 6,250 shares at $8.13 6.1% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  9. Zhenyu Xu Chief Scientific Officer
    Planned sale
    $89K 10,000 shares at $8.91 1.8% of stake
    Traded Aug 27 Filed Aug 31
    ↗
  10. Philippe Menu Chief Medical Officer
    Planned sale
    $43K 5,000 shares at $8.68 2.3% of stake
    Traded Aug 25 Filed Aug 26
    ↗
  11. Kathy L Hibbs Director
    Planned sale
    $54K 6,250 shares at $8.68 5.7% of stake
    Traded Aug 25 Filed Aug 26
    ↗
  12. Abhimanyu Verma Chief Technology Officer
    Planned sale
    $85K 10,000 shares at $8.50 5.5% of stake
    Traded Aug 19–24 Filed Aug 26
    ↗
  13. Manuela Valente Chief People Officer
    Planned sale
    $79K 10,000 shares at $7.94 4.5% of stake
    Traded Aug 19 Filed Aug 21
    ↗
  14. Zhenyu Xu Chief Scientific Officer
    Planned sale
    $163K 20,000 shares at $8.17 3.4% of stake
    Traded Aug 19–21 Filed Aug 21
    ↗
  15. Philippe Menu Chief Medical Officer
    Planned sale
    $38K 5,000 shares at $7.52 2.2% of stake
    Traded Aug 12 Filed Aug 14
    ↗

Also filed in the last 12 months, not counted as buying or selling: 92 sales to cover taxes, 14 stock grants, and 7 option exercises.

SEC filings

Recent issuer filings from EDGAR, 1 shown.

Filed Form Detail Links
6-K Filing Doc

Source: SEC EDGAR submissions, updated 9 days ago. All on EDGAR

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.